Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
Recruiting · NCT06548711 · Interventional (participants receive a specific treatment) · Lead sponsor: Kong Fanming
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Observation and exploration of the improvement in cough symptoms in postoperative lung cancer patients with Transcutaneous Acupoint Electrical Stimulation (TAES), the change in Cough Symptom Score (CSS) compared to baseline, the change in Visual Analog Scale (VAS) score for cough symptoms compared to baseline, the change in total score of Leicester Cough Questionnaire-Mandarin Chinese version (LCQ-MC) compared to baseline, and overall evaluation of treatment effectiveness by patients. A total of 84 postoperative lung cancer patients with cough were strictly selected according to the inclusion/exclusion criteria and treated and followed up according to the research plan requirements. Clinical observation forms were completed and clinical data were recorded in the database. Statistical analysis was performed on relevant clinical observation indicators to report research results and write related papers.
Who can take part
Inclusion criteria
- Age between 18 and 80 years old - Surgery performed under general anesthesia for radical resection of lung cancer or lung cancer resection combined with lymph node dissection.
- Pathological confirmation of primary lung cancer after surgery.
- Duration of persistent dry cough after lung surgery ≥2 weeks.
- Consciousness, ability to express opinions clearly, and voluntary signing of informed consent.
Exclusion criteria
- Patients diagnosed with acute respiratory system diseases within 1 month.
- Patients diagnosed with pneumonia based on chest X-ray.
- Patients with a history of asthma or tuberculosis.
- Patients with uncontrolled hyperthyroidism, severe hypertension, heart disease, systemic infection, coagulation disorders (hypercoagulable state or bleeding tendency), or other severe systemic diseases.
- Patients who have used steroid drugs within the past 3 months.
- Patients who have taken angiotensin-converting enzyme inhibitors (ACEIs) within the past 6 months.
- Patients with surgical incisions, skin allergies, wounds, or infections in the treatment area.
- Patients who cannot tolerate transcutaneous acupoint electrical stimulation or withdraw during the procedure.
- Patients with contraindications to transcutaneous electrical stimulation or implanted electrophysiological devices.
- Patients who are pregnant or breastfeeding.
Where it is running
1 location listed.
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine - Tianjin, Tianjin Municipality, China